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Sclerosing stromal tumor (SST) is histologically benign and ac-
counts for 6% of the tumors derived from the stroma of the ovaries
[1]. The patients who are diagnosed with an SST are predominantly
in their 20s and 30s, unlike other stromal tumors [2,3]. Clinical
imaging by magnetic resonance imaging (MRI) shows high vascu-
larity and a solid part in SSTs. Many cases are suspected as a ma-
lignant tumor before surgery, during which, a unilateral ovary is
removed without partial preservation.
Case 1: A 25-year-old woman, gravida 0, para 0 who reported
that she had never had sexual intercourse was admitted with the
complaint of irregular and frequent menstruation every
15e30 days. A 10-cm-diameter pelvic mass at the front of the
uterus was revealed by transrectal ultrasonography. MRI showed
ﬁndings suggesting a possible malignant tumor in the right ovary
(Figure 1). Gastroscopy and colon ﬁberoscopy were normal.
Enhanced computed tomography showed no enlarged pelvic or
para-aortic lymph nodes and no metastasis. The ﬁndings related to
tumor markers [carbohydrate antigen (CA)-125, CA19-9, CA72-4,
and human chorionic gonadotropin) and a hormonal analysis was
within normal limits.
A right salpingo-oophorectomywasperformedbecause the lesion
wasmostly a solid tumor, but edematouswithyellowisheclear liquid
(Figure 1). A fresh specimen from the solid part was used to obtain a
frozen section, and massive ovarian edema was diagnosed.* Corresponding author. Department of Obstetrics and Gynecology, Faculty of Medicin
E-mail address: tomokoh@oita-u.ac.jp (T. Hirakawa).
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).The histopathological ﬁndings, stained by hematoxylin and
eosin, are shown in Figure 1. Immunopositive ﬁndings for CD34,
cytokeratin (AE1/AE3), smooth muscle actin, vimentin, and a-
inhibin were obtained. The ﬁnal diagnosis was SST. In addition,
vascular endothelial growth factor (VEGF) was also positive. After
surgery, the patient's menstrual cycle became regular.
Case 2 : A 24-year-old woman, gravida 0, para 0, was admitted
with the complaint of irregular menstruation. Her menstrual cycle
was between 15 days and 30 days. An 8-cm-diameter pelvic mass
with a solid part at the right side of the uterus was revealed by
transvaginal ultrasonography. MRI showed ﬁndings suggesting a
possible malignant tumor in the right ovary. The results of a hor-
mone assay were within normal limits. CA-125 was 79.5 U/mL;
however, other tumor markers showed no elevation. A right
salpingo-oophorectomy was performed (Figure 2). A fresh spec-
imenwas used to obtain a frozen section, and SST was the tentative
diagnosis. The hematoxylin and eosin and immunohistopatho-
logical staining ﬁndings are shown in Figure 2. Immunopositive
ﬁndings for smooth muscle actin, vimentin, a-inhibin, desmin, and
MIC2/CD99 were obtained. VEGF was also positive (Figure 2). AE1/
AE3 and CA-125 were not detected. Her menstrual cycle became
regular.
The patients diagnosed with an SST are predominantly young,
and they tend to undergo unilateral ovary resection. The high
vascularity of SST in clinical imaging is one of the reasons for sus-
picion of a malignant tumor before surgery.
We suspect that thin-walled small vessels are related to the
expression of VEGF in SSTs. There are a few reports concerning the
expression of VEGF in SSTs [4,5]. In our cases, both SSTs were more
strongly stained by antihuman VEGF antibody compared to a con-
trol group. In the near future, the early diagnosis of SST using a
VEGF examination could help clinicians decide on the operative
method.e, Oita University, Idaigaoka 1-1, Hasama-machi, Yufu-shi, Oita 879-5593, Japan.
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Figure 1. Case 1. (A) Pelvic magnetic resonance imaging revealed mainly a cystic mass, with a peripheral solid part; septa are shown. The ﬂow void indicates high vascularity. (B)
Macroscopic ﬁndings of the right ovary. The tumor was edematous and mostly solid, with yellowisheclear liquid. (C) Hematoxylin and eosin staining showed a pseudolobular
pattern composed of ﬁbroblasts and rounded vasculated cells. (D) Immunohistopathological staining by antihuman vascular endothelial growth factor antibody.
Figure 2. Case 2. (A) Pelvic magnetic resonance imaging revealed a multicystic mass with a peripheral solid part. (B) Macroscopic ﬁndings: the mass was yellowish and solid. (C)
Hematoxylin and eosin staining showing a pseudolobular pattern composed of ﬁbroblasts and rounded vacuolated cells. (D) Immunohistopathological staining by antihuman
vascular endothelial growth factor antibody.
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